4SC
4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious, and provide a better quality of life.
4SC
Industry:
Biopharma Biotechnology Therapeutics
Founded:
1997-01-01
Address:
Planegg, Bayern, Germany
Country:
Germany
Website Url:
http://www.4sc.de
Total Employee:
51+
Status:
Active
Contact:
+490897007630
Email Addresses:
[email protected]
Total Funding:
94.7 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins Yoast WordPress SEO Plugin Yoast SEO Premium Yoast Plugins
Similar Organizations
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Cue Biopharma
Cue Biopharma has developed a highly productive platform for the treatment of cancer and autoimmune disease.
Nurix Therapeutics
Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.
Current Employees Featured
Stock Details
Investors List
Santo Holding
Santo Holding investment in Post-IPO Equity - 4SC
Wellington Partners
Wellington Partners investment in Post-IPO Equity - 4SC
Deutsche Venture Capital
Deutsche Venture Capital investment in Series C - 4SC
Mulligan BioCapital
Mulligan BioCapital investment in Series C - 4SC
BionXâ„¢ Medical Technologies
BionXâ„¢ Medical Technologies investment in Series C - 4SC
3i Group
3i Group investment in Series C - 4SC
Beteiligungsgesellschaft Neue Länder
Beteiligungsgesellschaft Neue Länder investment in Series B - 4SC
BioM AG
BioM AG investment in Series B - 4SC
Deutsche Venture Capital
Deutsche Venture Capital investment in Series B - 4SC
Bayern Kapital
Bayern Kapital investment in Series B - 4SC
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2015-11-02 | Panoptes Pharma | 4SC investment in Seed Round - Panoptes Pharma | N/A |
| 2008-05-26 | Nexigen | 4SC investment in Funding Round - Nexigen | N/A |
Official Site Inspections
http://www.4sc.de Semrush global rank: 9.75 M Semrush visits lastest month: 113
- Host name: 46.30.63.120
- IP address: 46.30.63.120
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "4SC"
4SC AG - Entwicklung effektiver Medikamente für Krebspatienten
Mar 28, 2025 4SC ist ein innovatives biopharmazeutisches Unternehmen mit Sitz in Planegg-Martinsried bei München, mit Fokus auf Medikamentenentwicklung im Bereich Onkologie. Wir …See details»
4SC - Development of innovative cancer drugs
Headquartered in Planegg-Martinsried near Munich/Germany, 4SC is an innovative biopharmaceutical company with a strong focus on product development in oncology. We …See details»
Company - 4SC AG
Mar 13, 2025 4SC’s goal is to advance its own drug development programs in order to increase the value of the Company as a whole through entering into valuable partnerships with …See details»
Unternehmen - 4SC AG
Mar 28, 2025 Das Ziel von 4SC besteht darin, die eigenen Programme zur Medikamentenentwicklung voranzubringen und die letztendlich zugelassenen Wirkstoffe in …See details»
Investoren & Medien - 4SC AG
4SC veröffentlicht Q1 Mitteilung 2025. 28. Mar 2025. 4SC AG berichtet über Ergebnisse des Geschäftsjahres 2024 und veröffentlicht Ausblick. 13. Mar 2025. 4SC AG gibt Update zum …See details»
4SC - Crunchbase Company Profile & Funding
4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended …See details»
Corporate Governance - 4SC AG
Good, transparent corporate governance is a top priority for 4SC. The company is committed to the German Corporate Governance Code with respect to its goals, values and processes. 4SC …See details»
4SC – Wikipedia
Die 4SC AG erforscht und entwickelt zielgerichtet wirkende Therapien (Targeted Therapies) zur Behandlung von Krebs. [2] Unternehmen. Die 4SC AG wurde 1997 gegründet. Mitgründer …See details»
4SC AG - LinkedIn
4SC AG | 2,301 followers on LinkedIn. Small molecule drug development in oncology | 4SC is headquartered in Planegg-Martinsried near Munich, Germany. The Company had 30 FTEs as …See details»
4SC - businessabc
Feb 25, 2025 4SC AG was founded in 1997. In 1998, 4SC began collaborating with Boehringer Mannheim GmbH in the area of cancer research. In 2004, 4SC acquired Hematolin GmbH, …See details»
4SC AG - Bayern International – Competence for International …
4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. 4SC’s pipeline is protected by …See details»
4SC AG, Financial Info, Board and Management, Remuneration
Market Cap (EUR) NOTES: †- Upcoming company / Assignment in upcoming company ♘ - Unicorn company Δ - Growth company â„— - Portfolio company ň - New company …See details»
4SC Company Profile - Office Locations, Competitors, Revenue
Oct 29, 2024 4SC is a biopharmaceutical company developing small-molecule drugs that target key indications in cancer with unmet medical needs. Its current product pipeline includes two …See details»
Investors & Media - 4SC AG
4SC announces further EMA feedback relating to Resminostat’s (Kinselby) Marketing Authorisation Application. 17. Apr 2025. 4SC publishes Q1 2025 report. 28. Mar 2025. 4SC …See details»
4 SC AG konv. Aktie - DER AKTIONÄR
Die 4SC AG ist ein Life-Science-Konzern, der medizinische Wirkstoffe erforscht und entwickelt. Die von 4SC hergestellten niedermolekularen Medikamente wirken zielgerichtet und werden …See details»
4SC - Products, Competitors, Financials, Employees, Headquarters …
4SC is a biopharmaceutical company focused on the development of novel medications in the oncology sector. Use the CB Insights Platform to explore 4SC's full profile. 4SC - Products, …See details»
4SC AG - Martinsried, Deutschland - bionity.com
May 3, 2016 4sc.de +49897007630. Teilen. Xing Linkedin Facebook X E-mail Loading... Merken. Merkliste aufrufen; Merken. 4SC AG. Am Klopferspitz 19 A 82152 Martinsried …See details»
4sc - Overview, News & Similar companies | ZoomInfo.com
Mar 11, 2020 Who is 4sc. 4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that target key indications in cancer with high unmet medical needs. …See details»
4SC AG berichtet über Ergebnisse des Geschäftsjahres 2022 und ...
Mar 13, 2025 Planegg-Martinsried, 17. März 2023 – Die 4SC AG (4SC, FWB Prime Standard: VSC) hat heute die Finanzergebnisse für das am 31. Dezember 2022 abgelaufene Geschäftsjahr und einen Ausblick für 2023 veröffentlicht. Der vollständige Geschäftsbericht kann auf der 4SC Homepage heruntergeladen werden. Wichtige Ereignisse im Jahr 2022See details»
4SC AG berichtet über Ergebnisse des Geschäftsjahres 2024 und ...
Mar 28, 2025 Im Mai 2024 ging 4SC eine Partnerschaft mit Vuja De Sciences, Inc., New Jersey, USA (Vuja De) ein – einem US-amerikanischen Unternehmen, das sich auf die Erprobung von …See details»